MDVN
MDVN Articles
In a new research report, the boutique firm Leerink highlights 10 top biotech names that are strong candidates for a partnership or acquisition. Any of these picks may be a great addition for...
Published:
Biotech and emerging pharmaceutical stocks continue to be hot, but short sellers shied away from many of them in late February. Those bucking that trend include BioMarin Pharmaceutical and Medivation.
Published:
Shares of Dendreon moved higher Monday after the biotech company said it will start to market Provenge, its prostate-cancer drug, in Europe this year. Its fourth-quarter loss was smaller than...
Published:
Jon OggThe higher the market goes, the more likely analysts are to pull the trigger on names they think are stretched. The problem for analysts: In a hot market, stocks often go higher when they are...
Published:
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on the final day of February 2014. The include Deckers Outdoor, InterMune, MarkWest Energy...
Published:
With top biotechnology and health care companies from around the world attending the Leerink Global Healthcare, it is a good chance for investors to get timely updates on the top stocks and their...
Published:
Like many firms on Wall Street, the biotechnology team at UBS thinks that most of the top mega-cap and large cap biotech stocks are poised to beat earnings estimates across the board. Investors who...
Published:
The analysts at UBS are not only bullish on the biotechnology sector, they think there is a very distinct possibility that some of the top names may also become takeover targets this year.
Published:
ThinkstockCredit Suisse is out and pounding the table that biotechnology cannot be ignored in 2014. Biotech has been the top-performing sector for the past three years, with year-to-date performance...
Published:
Last Updated:
ThinkstockAny time investors look for companies growing sales the most, one area that almost always stands out is the up and coming biotech stocks. After all, sales can grow from close to nothing...
Published:
ThinkstockMany Wall Street analysts and strategists are forecasting a rise in corporate earnings for the rest of the year and throughout 2014. That is music to the ears of stock investors. Rising...
Published:
Last Updated:
ThinkstockThe UBS proprietary institutional flow data indicates that hedge funds are increasing exposure to financials and decreasing exposure to health care. Given that health care has outperformed...
Published:
Last Updated:
Wikimedia CommonsThe leading firms on Wall Street maintain a list of their top stocks to buy as their highest conviction calls from the top analysts in the firm. What is somewhat rare is to see a...
Published:
Last Updated:
ThinkstockThe world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not change all that much, the manner in which it can be treated does....
Published:
Last Updated:
ThinkstockTuesday saw the wrap up of the 2013 European Society of Medical Oncology (ESMO) conference in Amsterdam, which featured key data from several of the companies covered by the biotech...
Published:
Last Updated: